NARCRMS will provide our supporters with information to help formulate sound product

development plans for continuing research into the diagnosis, treatment, and potential eradication of MS. The longitudinal database will help identify patients who should be recruited into clinical trials, making studies smaller, cheaper, and more effective.

Our current industry sponsors include:

  • Acorda Therapeutics, Inc.
  • Bayer Healthcare Pharmaceuticals, Inc.
  • Biogen
  • EMD Serono, Inc.
  • Genentech Inc.
  • Genzyme
  • Mallinckrodt Pharmaceuticals
  • Mylan
  • Novartis Pharmaceutical Corporation
  • Teva Neuroscience